AMGN vs SPOK · P/E 24, rev $10.05B vs P/E 17, rev $68.2M
Amgen Inc (AMGN) versus Spok Holdings Inc (SPOK) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Spok Holdings Inc (SPOK) is a health information services company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SPOK revenue for 2026-06-30 was $68.2M. Net income was $6.1M. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
Not investment advice. Open the AMGN and SPOK stock pages for the full models.
Not investment advice.